Cigarette Smoking in Methadone Maintained Patients: An up-to-Date Review

Current Drug Abuse Reviews

Volumn 6, Issue 1, 2013, Pages 77-84

  Zirakzadeh, Ali ^a,b   Shuman, Charles ^a,b   Stauter, Erinn ^b   Hays, J Taylor ^c   Ebbert, Jon O ^c  

^a DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Cigarette; Methadone; Nicotine; Opioids; Substance abuse; Tobacco

Indexed keywords

AMFEBUTAMONE; METHADONE; NICOTINE; PLACEBO; VARENICLINE;

ADVERSE OUTCOME; ARTICLE; BEHAVIOR THERAPY; DRUG DEPENDENCE; DRUG EFFICACY; HUMAN; METHADONE TREATMENT; NICOTINE REPLACEMENT THERAPY; NONHUMAN; OPIATE ADDICTION; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL; SMOKING CESSATION; SMOKING HABIT; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

BEHAVIOR, ADDICTIVE; DRUG INTERACTIONS; HUMANS; METHADONE; NARCOTICS; NICOTINE; NICOTINIC AGONISTS; OPIOID-RELATED DISORDERS; PREVALENCE; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME; UNITED STATES;

EID: 84880155600     PISSN: 18744737     EISSN: 18744745     Source Type: Journal    
DOI: 10.2174/1874473711306010009     Document Type: Article

References (81)

1. Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004. MMWR Morb Mortal Wkly Rep 2008; 57(45): 1226-8.
2. Hatsukami DK, Henningfield JE, Kotlyar M. Harm reduction approaches to reducing tobacco-related mortality. Annu Rev Public Health 2004; 25: 377-95.
3. Vital signs: current cigarette smoking among adults aged >/=18 years---United States, 2005--2010. MMWR Morb Mortal Wkly Rep 2011; 60: 1207-12.
4. Grant BF, Hasin DS, Chou SP, et al. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2004; 61(11): 1107-15.
5. Substance Abuse and Mental Health Services Administration. Alcohol and Drug Services Study (ADSS). The National Treatment System: Outpatient Methadone Facilities. Rockville, MD: Office of Applied Studies 2004.
6. Guydish J, Passalacqua E, Tajima B, et al. Smoking prevalence in addiction treatment: a review. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco. 2011 Jun;13(6):401-11.
7. Frosch DL, Shoptaw S, Nahom D, et al. Associations between tobacco smoking and illicit drug use among methadone-maintained opiate-dependent individuals. Exp Clin Psychopharmacol 2000; 8(1): 97-103.
8. Richter KP, Gibson CA, Ahluwalia JS, et al. Tobacco use and quit attempts among methadone maintenance clients. Am J Public Health 2001; 91(2): 296-9.
9. Nahvi S, Richter K, Li X, et al. Cigarette smoking and interest in quitting in methadone maintenance patients. Addict Behav 2006; 31(11): 2127-34.
10. Chatham LR, Hiller ML, Rowan-Szal GA, et al. Gender differences at admission and follow-up in a sample of methadone maintenance clients. Subst Use Misuse 1999; 34(8): 1137-65.
11. Stark MJ, Campbell BK. A psychoeducational approach to methadone maintenance treatment: a survey of client reactions. J Subst Abuse Treat 1991; 8(3): 125-31.
12. Sees KL, Clark HW. When to begin smoking cessation in substance abusers. J Subst Abuse Treat 1993; 10(2): 189-95.
13. Clemmey P, Brooner R, Chutuape MA, et al. Smoking habits and attitudes in a methadone maintenance treatment population. Drug Alcohol Depend 1997; 44(2-3): 123-32.
14. Clarke JG, Stein MD, McGarry KA, et al. Interest in smoking cessation among injection drug users. The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions. [Research Support, U.S. Gov't, P.H.S.]. 2001 Spring;10(2):159-66.
15. Kim TW, Alford DP, Malabanan A, et al. Low bone density in patients receiving methadone maintenance treatment. Drug Alcohol Depend. 2006 Dec 1;85(3):258-62.
16. Maxwell JC, Pullum TW, Tannert K. Deaths of clients in methadone treatment in Texas: 1994-2002. Drug and alcohol dependence. [Comparative Study]. 2005 Apr 4;78(1):73-81.
17. Hurt RD. Smoking cessation in primary care. Indiana Med. 1996 Mar-Apr;89(2):165-8.
18. Hurt RD, Offord KP, Croghan IT, et al. Mortality following inpatient addictions treatment. Role of tobacco use in a communitybased cohort. JAMA. 1996 Apr 10;275(14):1097-103.
19. Engstrom A, Adamsson C, Allebeck P, et al. Mortality in patients with substance abuse: a follow-up in Stockholm County, 1973-1984. The International journal of the addictions. [Research Support, Non-U.S. Gov't]. 1991 Jan;26(1):91-106.
20. Fareed A, Casarella J, Amar R, et al. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts. J Psychiatr Pract. [Research Support, Non-U.S. Gov't]. 2009 May;15(3):227-34.
21. Rosen D, Smith ML, Reynolds CF, 3rd. The prevalence of mental and physical health disorders among older methadone patients. Am J Geriatr Psychiatry. [Research Support, Non-U.S. Gov't]. 2008 Jun;16(6):488-97.
22. McClave AK, Whitney N, Thorne SL, et al. Adult tobacco survey-19 States, 2003-2007. MMWR Surveill Summ. 2010 Apr 16;59(3):1-75.
23. Abbott PJ. Case management: ongoing evaluation of patients' needs in an opioid treatment program. Prof Case Manag. [Evaluation Studies]. 2010 May-Jun;15(3):145-52.
24. Richter KP, McCool RM, Catley D, et al. Dual pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients. Journal of addictive diseases. [Clinical TrialResearch Support, N.I.H., Extramural]. 2005;24(4):79-90.
25. Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guidelines. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service; May 2008.
26. Silagy C, Lancaster T, Stead L, et al. Nicotine replacement therapy for smoking cessation. Cochrane database of systematic reviews (Online). 2004(3):CD000146.
27. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane database of systematic reviews (Online). 2008(1):CD000146.
28. Mansvelder HD, Fagen ZM, Chang B, et al. Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area. Biochem Pharmacol. [Research Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.]. 2007 Oct 15;74(8):1283-91.
29. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane database of systematic reviews. [Meta-Analysis Review]. 2007(1):CD000031.
30. Aubin HJ, Bobak A, Britton JR, et al. Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. Thorax. [Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't]. 2008 Aug;63(8):717-24.
31. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane database of systematic reviews. [Meta-Analysis Review]. 2007(1):CD006103.
32. Lasser K, Boyd JW, Woolhandler S, et al. Smoking and mental illness: A population-based prevalence study. Jama. 2000 Nov 22-29;284(20):2606-10.
33. Okoli CT, Khara M, Procyshyn RM, et al. Smoking cessation interventions among individuals in methadone maintenance: a brief review. Journal of substance abuse treatment. [Research Support, Non-U.S. Gov't Review]. 2010 Mar;38(2):191-9.
34. Haug NA, Svikis DS, Diclemente C. Motivational enhancement therapy for nicotine dependence in methadone-maintained pregnant women. Psychology of addictive behaviors: journal of the Society of Psychologists in Addictive Behaviors. [Clinical Trial Randomized Controlled Trial Research Support, U.S. Gov't, P.H.S.]. 2004 Sep;18(3):289-92.
35. Shoptaw S, Jarvik ME, Ling W, et al. Contingency management for tobacco smoking in methadone-maintained opiate addicts. Addict Behav. 1996 May-Jun;21(3):409-12.
36. Stein MD, Weinstock MC, Herman DS, et al. A smoking cessation intervention for the methadone-maintained. Addiction. [Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural]. 2006 Apr;101(4):599-607.
37. Reid MS, Fallon B, Sonne S, et al. Smoking cessation treatment in community-based substance abuse rehabilitation programs. Journal of substance abuse treatment. [Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural]. 2008 Jul;35(1):68-77.
38. Shoptaw S, Rotheram-Fuller E, Yang X, et al. Smoking cessation in methadone maintenance. Addiction. [Clinical Trial Multicenter Study Randomized Controlled Trial Research Support, U.S. Gov't, P.H.S.]. 2002 Oct;97(10):1317-28; discussion 25.
39. Campbell BK, Wander N, Stark MJ, et al. Treating cigarette smoking in drug-abusing clients. Journal of substance abuse treatment. [Clinical Trial Comparative Study Randomized Controlled Trial Research Support, Non-U.S. Gov't]. 1995 Mar-Apr;12(2):89-94.
40. Dunn KE, Sigmon SC, Reimann EF, et al. A contingencymanagement intervention to promote initial smoking cessation among opioid-maintained patients. Experimental and clinical psychopharmacology. [Comparative Study Randomized Controlled Trial Research Support, N.I.H., Extramural]. 2010 Feb;18(1):37-50.
41. Poling J, Rounsaville B, Gonsai K, et al. The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study. The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions. [Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.]. 2010 Sep-Oct;19(5):401-8.
42. Stein MD, Anderson BJ, Niaura R. Smoking cessation patterns in methadone-maintained smokers. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco. [Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural]. 2007 Mar;9(3):421-8.
43. Reid MS, Jiang H, Fallon B, et al. Smoking Cessation Treatment among Patients in Community-Based Substance Abuse Rehabilitation Programs: Exploring Predictors of Outcome as Clues Toward Treatment Improvement. The American journal of drug and alcohol abuse. 2011 Sep;37(5):472-8.
44. Frosch DL, Nahom D, Shoptaw S. Optimizing smoking cessation outcomes among the methadone maintained. Journal of substance abuse treatment. [Research Support, U.S. Gov't, P.H.S.]. 2002 Dec;23(4):425-30.
45. Stein MD, Weinstock MC, Anderson BJ, et al. Relationship of depression to smoking outcomes in a methadone-maintained population. Journal of addictive diseases. [Randomized Controlled Trial Research Support, N.I.H., Extramural]. 2007;26(1):35-40.
46. Sonne S, Nunes EV, Jiang H, et al. The Relationship Between Depression and Smoking Cessation Outcomes in Treatment-Seeking Substance Abusers. Am J Addict. 2010;19(2)(March 1):111-8.
47. Lemon SC, Verhoek-Oftedahl W, Donnelly EF. Preventive healthcare use, smoking, and alcohol use among Rhode Island women experiencing intimate partner violence. J Womens Health Gend Based Med. 2002 Jul-Aug;11(6):555-62.
48. Hser YI, McCarthy WJ, Anglin MD. Tobacco use as a distal predictor of mortality among long-term narcotics addicts. Prev Med. [Research Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, P.H.S.]. 1994 Jan;23(1):61-9.
49. Richter KP, Hamilton AK, Hall S, et al. Patterns of smoking and methadone dose in drug treatment patients. Experimental and clinical psychopharmacology. [Clinical TrialResearch Support, N.I.H., Extramural]. 2007 Apr;15(2):144-53.
50. Elkader AK, Brands B, Selby P, et al. Methadone-nicotine interactions in methadone maintenance treatment patients. J Clin Psychopharmacol. [Randomized Controlled TrialResearch Support, Non-U.S. Gov't]. 2009 Jun;29(3):231-8.
51. Chait LD, Griffiths RR. Effects of methadone on human cigarette smoking and subjective ratings. J Pharmacol Exp Ther. [Clinical TrialControlled Clinical Trial Research Support, U.S. Gov't, P.H.S.]. 1984 Jun;229(3):636-40.
52. Spiga R, Martinetti MP, Meisch RA, et al. Methadone and nicotine self-administration in humans: a behavioral economic analysis. Psychopharmacology (Berl). [Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.]. 2005 Mar;178(2-3):223-31.
53. Spiga R, Schmitz J, Day J, 2nd. Effects of nicotine on methadone self-administration in humans. Drug and alcohol dependence. [Clinical TrialControlled Clinical TrialResearch Support, U.S. Gov't, P.H.S.]. 1998 Apr 1;50(2):157-65.
54. Story J, Stark MJ. Treating cigarette smoking in methadone maintenance clients. Journal of psychoactive drugs. [Clinical Trial Controlled Clinical Trial]. 1991 Apr-Jun;23(2):203-15.
55. Li L, Liu Y, Zhang Y, et al. Temporal changes of smoking status and motivation among Chinese heroin-dependent, methadonemaintained smokers. Addict Behav. [Research Support, Non-U.S. Gov't]. 2010 Oct;35(10):861-5.
56. Liu S, Zhou W, Zhang J, et al. Differences in cigarette smoking behaviors among heroin inhalers versus heroin injectors. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco. 2011 Nov;13(11):1023-8.
57. Klous MG, Van den Brink W, Van Ree JM, et al. Development of pharmaceutical heroin preparations for medical co-prescription to opioid dependent patients. Drug and Alcohol Dependence. [Research Support, Non-U.S. Gov't Review]. 2005 Dec 12;80(3):283-95.
58. Wahawisan J, Kolluru S, Nguyen T, et al. Methadone Toxicity Due to Smoking Cessation--A Case Report on the Drug-Drug Interaction Involving Cytochrome P450 Isoenzyme 1A2. The Annals of pharmacotherapy. 2011 Jun;45(6):e34.
59. Herrlin K, Segerdahl M, Gustafsson LL, et al. Methadone, ciprofloxacin, and adverse drug reactions. Lancet. 2000 Dec 16;356(9247):2069-70.
60. Eap CB, Bertschy G, Powell K, et al. Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone. J Clin Psychopharmacol. 1997 Apr;17(2):113-7.
61. Hukkanen J, Jacob Iii P, Peng M, et al. Effects of nicotine on cytochrome P450 2A6 and 2E1 activities. Br J Clin Pharmacol. [Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. 2010 Feb;69(2):152-9.
62. Shiran MR, Lennard MS, Iqbal MZ, et al. Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment. Br J Clin Pharmacol. [Research Support, Non-U.S. Gov't]. 2009 Jan;67(1):29-37.
63. Lu WJ, Bies R, Kamden LK, et al. Methadone: a substrate and mechanism-based inhibitor of CYP19 (aromatase). Drug Metab Dispos. [Research Support, N.I.H., Extramural]. 2010 Aug;38(8):1308-13.
64. Tournier N, Chevillard L, Megarbane B, et al. Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). Int J Neuropsychopharmacol. 2010 Aug;13(7):905-15.
65. Meresaar U, Nilsson MI, Holmstrand J, et al. Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method. Eur J Clin Pharmacol. 1981;20(6):473-8.
66. Iribarne C, Berthou F, Baird S, et al. Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Chemical research in toxicology. [Research Support, Non-U.S. Gov't]. 1996 Mar;9(2):365-73.
67. Moody DE, Alburges ME, Parker RJ, et al. The involvement of cytochrome P450 3A4 in the N-demethylation of L-alphaacetylmethadol (LAAM), norLAAM, and methadone. Drug metabolism and disposition: the biological fate of chemicals. [Research Support, U.S. Gov't, P.H.S.]. 1997 Dec;25(12):1347-53.
68. Crettol S, Deglon JJ, Besson J, et al. ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment. Clinical pharmacology and therapeutics. [Multicenter Study Research Support, Non-U.S. Gov't]. 2006 Dec;80(6):668-81.
69. Chang Y, Fang WB, Lin SN, et al. Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation. Basic & clinical pharmacology & toxicology. [Research Support, N.I.H., Extramural]. 2011 Jan;108(1):55-62.
70. Tacke U, Wolff K, Finch E, et al. The effect of tobacco smoking on subjective symptoms of inadequacy (not holding) of methadone dose among opiate addicts in methadone maintenance treatment. Addict Biol. 2001 Apr;6(2):137-45.
71. Wang JS, DeVane CL. Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)-and (S)-methadone in vitro. Drug metabolism and disposition: the biological fate of chemicals. [In Vitro Research Support, U.S. Gov't, P.H.S.]. 2003 Jun;31(6):742-7.
72. Conte-Devolx B, Oliver C, Giraud P, et al. Effect of nicotine on in vivo secretion of melanocorticotropic hormones in the rat. Life sciences. [Research Support, Non-U.S. Gov't]. 1981 Mar 2;28(9):1067-73.
73. Marty MA, Erwin VG, Cornell K, et al. Effects of nicotine on betaendorphin, alpha MSH, and ACTH secretion by isolated perfused mouse brains and pituitary glands, in vitro. Pharmacology, biochemistry, and behavior. [In Vitro Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. 1985 Feb;22(2):317-25.
74. Hexum TD, Russett LR. Plasma enkephalin-like peptide response to chronic nicotine infusion in guinea pig. Brain research. [Research Support, Non-U.S. Gov't]. 1987 Mar 17;406(1-2):370-2.
75. Pierzchala K, Houdi AA, Van Loon GR. Nicotine-induced alterations in brain regional concentrations of native and cryptic Met-and Leu-enkephalin. Peptides. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.]. 1987 Nov-Dec;8(6):1035-43.
76. Houdi AA, Pierzchala K, Marson L, et al. Nicotine-induced alteration in Tyr-Gly-Gly and Met-enkephalin in discrete brain nuclei reflects altered enkephalin neuron activity. Peptides. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.]. 1991 Jan-Feb;12(1):161-6.
77. Pomerleau OF, Fertig JB, Seyler LE, et al. Neuroendocrine reactivity to nicotine in smokers. Psychopharmacology (Berl). [Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.]. 1983;81(1):61-7.
78. Seyler LE, Jr., Pomerleau OF, Fertig JB, et al. Pituitary hormone response to cigarette smoking. Pharmacology, biochemistry, and behavior. [Research Support, U.S. Gov't, Non-P.H.S.]. 1986 Jan;24(1):159-62.
79. Berrendero F, Mendizabal V, Robledo P, et al. Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. The Journal of neuroscience: the official journal of the Society for Neuroscience. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. 2005 Feb 2;25(5):1103-12.
80. Berrendero F, Kieffer BL, Maldonado R. Attenuation of nicotineinduced antinociception, rewarding effects, and dependence in muopioid receptor knock-out mice. The Journal of neuroscience: the official journal of the Society for Neuroscience. [Research Support, Non-U.S. Gov't]. 2002 Dec 15;22(24):10935-40.
81. Gorelick DA, Rose J, Jarvik ME. Effect of naloxone on cigarette smoking. Journal of substance abuse. [Clinical TrialRandomized Controlled Trial Research Support, Non-U.S. Gov't]. 1988;1(2):153-9.